Thorotrast-induced liver neoplasia: A collective review

Journal of the American College of Surgeons

Volumn 195, Issue 5, 2002, Pages 713-718

  Lipshutz, Gerald S ^a   Brennan, Todd V ^a   Warren, Robert S ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

THORIUM DIOXIDE;

AGED; ALPHA RADIATION; ANGIOSARCOMA; ANIMAL EXPERIMENT; BILE DUCT CANCER; BILE DUCT CARCINOMA; CANCER RISK; CASE REPORT; CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; DNA DAMAGE; GENE MUTATION; GRANULOMA; HEMANGIOENDOTHELIOSARCOMA; HUMAN; IONIZING RADIATION; LIVER ADENOMA; LIVER CELL CARCINOMA; LIVER DISEASE; LIVER INJURY; LIVER TUMOR; LONG TERM EXPOSURE; MALE; MALIGNANT TRANSFORMATION; PRIORITY JOURNAL; RADIATION DOSE; RADIATION EXPOSURE; RETICULOENDOTHELIAL NEOPLASM; REVIEW;

EID: 0036842596     PISSN: 10727515     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1072-7515(02)01287-5     Document Type: Article

References (47)

1. Travis LB, Kathren RL, Boice JD. Cancer risk following exposure to Thorotrast: Overview in relation to a case report. Health Phys 1992;63:89-97.
2. Abbatt JD. History of the use and toxicity of thorotrast. Environ Res 1979;18:6-12.
3. Kamikawa T, Amenomori M, Itoh T, et al. Analysis of genetic changes in intrahepatic cholangiocarcinoma induced by Thorotrast. Radiat Res 1999;152:118-124.
4. Srinivasan R, Dean HA. Thorotrast and the liver-revisited. J Toxicol Clin Toxicol 1997;35:199-202.
5. Levy DW, Rindsberg S, Friedman AC, et al. Thorotrast-induced hepatosplenic neoplasia: CT identification. Am J Roentgenol 1986;146:997-1004.
6. MacMahon HE, Murphy AS, Bates MI. Endothelial-cell sarcoma of liver following Thorotrast injections. Am J Pathol 1947;23:585-611.
7. Iwamoto KS, Mizuno T, Kurata A, et al. Multiple, unique, and common p53 mutations in a Thorotrast recipient with four primary cancers. Hum Pathol 1998;29:412-416.
8. Masbou J, Valmary J, Bili H, et al. Simultaneous hepatic cholangiocarcinoma and bone fibrosarcoma 45 years after ingestion of Thorotrast. Gastroenterol Clin Biol 1995;19:120-122.
9. Shurbaji MS, Olson JL, Kuhajda FP. Thorotrast-associated hepatic leiomyosarcoma and cholangiocarcinoma in a single patient. Hum Pathol 1987;18:524-526.
10. Wargotz ES. Cutaneous Thorotrast granulomas and chronic lymphocytic leukemia following Thorotrast angiography. Am J Surg Pathol 1985;9:835-841.
11. Sakai K, Shiiha M, Ishihara N, Kato Y. Thorotrast-induced multiple primary malignant tumors of the livercholangiocarcinoma and malignant hemangioendothelioma. Jpn J Clin Oncol 1984;14:411-416.
12. Hirose Y, Konda S, Sasaki K, Konishi F, Takazakura E. Erythroleukemia and gastric cancer following Thorotrast injection. Jpn J Med 1991;30:43-46.
13. Lee FI, Tharakan J, Vasudev KS, Isaacs PE. Malignant hepatic tumours associated with previous exposure to Thorotrast: Four cases. Eur J Gastroenterol Hepatol 1996;8:1121-1124.
14. Ober S, Zerban H, Spiethoff A, et al. Preneoplastic foci of al tered hepatocytes induced in rats by irradiation with alphaparticles of Thorotrast and neutrons. Cancer Lett 1994;83:81-88.
15. Van Kaick G, Wesch H, Luhrs H, et al. Neoplastic diseases induced by chronic alpha-irradiation-epidemiological, biophysical and clinical results of the German Thorotrast Study. J Radiat Res 1991;32:20-33.
16. Baron HL, Bennett MD. Hepatography. Radiology 1957;78:710-718.
17. FindleyA, Childress MH. Computed tomography of thorotrastosis. J Compt Tomogr 1987;11:188-189.
18. Nguyen BT, Yousem DM, Hayden RE, Montone KT. Cervical thorium dioxide granuloma ('thorotrastoma'). Am J Neuroradiol 1995;16:1729-1732.
19. Polacarz SV, Laing RW, Loomes R. Thorotrast granuloma: An unexpected diagnosis. J Clin Pathol 1992;45:259-261.
20. Sitarik K, Freed KS, Sheafor DH. Thorotrast revisited: Contrast-induced hepatic neoplasm. Am J Roentgenol 1999;172:842-843.
21. Ito Y, Kojiro M, Nakashima T, Mori T. Pathomorphologic characteristics of 102 cases of thorotrast-related hepatocellular carcinoma, cholangiocarcinoma, and hepatic angiosarcoma. Cancer 1988;62:1153-1162.
22. Kiyosawa K, Haruhiko I, Takesahi S, et al. Comparison of anamnestic history, alcohol intake and smoking, nutritional status, and liver dysfunction between Thorotrast patients who developed primary liver cancer and those who did not. Environ Res 1989;49:166-172.
23. Van Kaick G, Dalheimer A, Hornik S, et al. The German Thorotrast Study: Recent results and assessment of risks. Radiat Res 1999;152:S64-S71.
24. Andersson M, Vyberg M, Visfeldt J, et al. Primary liver tumors among Danish patients exposed to Thorotrast. Radiat Res 1994;137:262-273.
25. Wesch H, van Kaick G, Riedel W, et al. Recent results of the German Thorotrast Study-statistical evaluation of animal experiments with regard to the nonradiation effects in human thorotrastosis. Health Phys 1983;44:317-321.
26. Kaul A, Foll U, Haase VA, et al. Microdistribution of thorotrast and dose to cellular structures. Environ Res 1979;18:13-22.
27. Irie H, Mori W, Mori T, et al. Ultrastructural localization of Thorotrast in human liver by analytical scanning electron microscope. Acta Pathol JpnM 1986;36:1871-1888.
28. Kato Y, Mori T, Kumatori T. Estimated absorbed dose in tissues and radiation effects in Japanese Thorotrast patients. Health Phys 1983;44:273-279.
29. Dagle GE, Moen EP, Adee RR, et al. Microdistribution and microdosimetry of thorium deposited in the liver. Health Phys 1992;63:41-45.
30. Wada I, Horiuchi H, Mori M, et al. High rate of small TP53 mutations and infrequent loss of heterozygosity in malignant liver tumors associated with Thorotrast: Implications for alphaparticle carcinogenesis. Radiat Res 1999;152:S125-S127.
31. Przygodzki RM, Finkelstein SD, Keohavong P, et al. Sporadic and Thorotrast-induced angiosarcomas of the liver manifest frequent and multiple point mutations in K-ras-2. Lab Invest 1997;76:153-159.
32. Van Kaick G, Muth H, Kaul A. The German Thorotrast Study. Results of Epidemiological, Clinical and Biophysical Examinations on Radiation-Induced Late Effects in Man Caused by Incorporated Colloidal Thorium Dioxide (Thorotrast). Luxembourg: Commission of the European Communities; Report Number EUR 9504 EN; 1984.
33. Kido C, Sasaki F, Hirota Y, et al. Cancer mortality of Thorotrast patients in Japan: The second series updated 1998. Radiat Res 1999;152:S81-S83.
34. Mori T, Kido C, Fukutomi K, et al. Summary of entire Japanese Thorotrast follow-up study: Updated 1998. Radiat Res 1999;152:S84-S87.
35. Mori T, Fukutomi K, Kato Y, et al. 1998 Results of the first series of follow-up studies on Japanese Thorotrast patients and their relationships to an autopsy series. Radiat Res 1999;152:S72-S80.
36. dos Santos Silva I, Jones M, Malveiro F, Swerdlow A. Mortality in the Portuguese Thorotrast study. Radiat Res 1999;152:S88-S92.
37. Tanosaki S, Minamihisamatsu M, Ishihara T, et al. Chromosome aberrations in bone marrow cells from Japanese patients with thorotrastosis. Radiat Res 1999;152:S128-S132.
38. Mole RH. Leukaemia induction in man by radionuclides and some relevant experimental and human observations. Strahlentherapie 1985;80:1-13.
39. da Motta LC, da Silva Horta J, Tavares MH. Prospective epidemiological study of Thorotrast-exposed patients in Portugal. Environ Res 1979;18:152-172.
40. National Academy of Sciences. Health Risks of Radon and Other Internally Deposited Alpha Emitters. Washington, DC: National Academy Press; BEIR IV Report; 1988.
41. Wegener K. Systematic review of thorotrast data and facts: Animal experiments. Virchows Arch A Pathol Anat Histol 1979;38:245-268.
42. Wegener K, Hasenohrl K, Wesch H. Recent results of the German Thorotrast Study-pathoanatomical changes in animal experiments and comparison to human thorotrastosis. Health Phys 1983;44:307-316.
43. Kamiyama R, Ishikawa Y, Hatakeyama S, et al. Clinicopathological study of hematological disorders after Thorotrast administration in Japan. Blur 1988;56:153-160.
44. Mole RH. Leukaemia induction in man by radionuclides and some relevant experimental and human observations. Strahlentherapie 1985;80:1-13.
45. Ishikawa Y, Mori T, Machinami R. Lack of apparent excess of malignant mesothelioma but increased overall malignancies of peritoneal cavity in Japanese autopsies with Thorotrast injection into blood vessels. J Cancer Res Clin Oncol 1995;121:567-570.
46. Johansen C. Tumors in rabbits after injection of various amounts of thorium dioxide. Ann NY Acad Sci 1967;45:724-727.
47. Hahn FF, Gilmette RA, Hoover MD. Implanted depleted uranium fragments cause soft tissue sarcomas in the muscles of rats. Environ Health Perspect 2002;110:51-59.